Epidermal Autograft Harvester Aids Chronic Wound Recovery
|
By HospiMedica International staff writers Posted on 14 Feb 2017 |

Image: The CelluTome Epidermal Harvesting System (Photo courtesy of Acelity).
A new skin-graft harvesting system aids in the treatment of chronic wounds and reduces care costs by accelerating the healing process.
The Acelity CelluTome Epidermal Harvesting System offers a minimally invasive epidermal grafting technique that creates minimal donor site damage and scarring, provides increased expansion ratios, and can be performed easily and in a relatively pain-free manner in the outpatient setting. The resultant epidermal graft can help to reduce healing time in both chronic and small acute wounds, with a potentially significant impact on the overall cost of chronic wound care.
The device works by creating multiple suction-induced epidermal blisters between two stainless steel plates with an array of 1.75-mm holes by using a constant negative pressure of 400-500 mmHg at a temperature of 37° to 41° C. The suction blisters develop inside the disposable harvester, with more than 128 blisters created over an area of 25 cm2 of donor skin. An integrated cutter blade is then used to separate the blisters, which are peeled away with a transparent dressing and applied over the recipient site.
In a study conducted at the University of Missouri Healthcare System that involved 13 patients with various types of chronic wounds, the CelluTome Epidermal Harvesting System grafts resulted in healing rates of 62%; eight of the 13 patients healed within four months, two were lost to follow-up, and three had wounds that remained open. In fact, four of the patients healed in less than one month. In addition, the comparatively rapid closure of the open wounds also reduced health care costs by an average of USD 1,153 per patient.
“Chronic wounds occur when healing fails to progress normally and persists for more than 30 days. Current treatments such as moist dressings, frequent irrigations, and wound cleaning are not always enough to ensure that healing occurs in high-risk patients,” said lead author Jeffrey Litt, DO. “Although a skin graft can be used to close a wound that refuses to heal, the surgical technique usually is painful, time-consuming and leaves significant donor site wounds.”
There are two types of skin grafts; a full thickness skin graft that consists of the epidermis and the entire thickness of the dermis, and a split-thickness skin graft that includes the epidermis and part of the dermis. Split-thickness grafts are frequently used as they can cover large areas and the rate of auto-rejection is low. The donor site heals by re-epithelialization from the dermis and surrounding skin and requires dressings.
The Acelity CelluTome Epidermal Harvesting System offers a minimally invasive epidermal grafting technique that creates minimal donor site damage and scarring, provides increased expansion ratios, and can be performed easily and in a relatively pain-free manner in the outpatient setting. The resultant epidermal graft can help to reduce healing time in both chronic and small acute wounds, with a potentially significant impact on the overall cost of chronic wound care.
The device works by creating multiple suction-induced epidermal blisters between two stainless steel plates with an array of 1.75-mm holes by using a constant negative pressure of 400-500 mmHg at a temperature of 37° to 41° C. The suction blisters develop inside the disposable harvester, with more than 128 blisters created over an area of 25 cm2 of donor skin. An integrated cutter blade is then used to separate the blisters, which are peeled away with a transparent dressing and applied over the recipient site.
In a study conducted at the University of Missouri Healthcare System that involved 13 patients with various types of chronic wounds, the CelluTome Epidermal Harvesting System grafts resulted in healing rates of 62%; eight of the 13 patients healed within four months, two were lost to follow-up, and three had wounds that remained open. In fact, four of the patients healed in less than one month. In addition, the comparatively rapid closure of the open wounds also reduced health care costs by an average of USD 1,153 per patient.
“Chronic wounds occur when healing fails to progress normally and persists for more than 30 days. Current treatments such as moist dressings, frequent irrigations, and wound cleaning are not always enough to ensure that healing occurs in high-risk patients,” said lead author Jeffrey Litt, DO. “Although a skin graft can be used to close a wound that refuses to heal, the surgical technique usually is painful, time-consuming and leaves significant donor site wounds.”
There are two types of skin grafts; a full thickness skin graft that consists of the epidermis and the entire thickness of the dermis, and a split-thickness skin graft that includes the epidermis and part of the dermis. Split-thickness grafts are frequently used as they can cover large areas and the rate of auto-rejection is low. The donor site heals by re-epithelialization from the dermis and surrounding skin and requires dressings.
Latest Critical Care News
- Noninvasive Monitoring Device Enables Earlier Intervention in Heart Failure
- Automated IV Labeling Solution Improves Infusion Safety and Efficiency
- First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
- 4D Digital Twin Heart Model Improves CRT Outcomes
- AI Turns Glucose Data Into Actionable Insights for Diabetes Care
- Microscale Wireless Implant Tracks Brain Activity Over Time
- Smart Mask Delivers Continuous, Battery-Free Breath Monitoring
- Routine Blood Pressure Readings May Identify Risk of Future Cognitive Decline
- CGM-Based Algorithm Enhances Insulin Dose Adjustment in Type 2 Diabetes
- Fish Scale–Based Implants Offer New Approach to Corneal Repair
- Dual-Function Wound Patch Combines Infection Sensing and Treatment
- Smartwatch Signals and Blood Tests Team Up for Early Warning on Insulin Resistance
- Smart Fabric Technology Aims to Prevent Pressure Injuries in Hospital Care
- Standardized Treatment Algorithm Improves Blood Pressure Control
- Combined Infection Control Strategy Limits Drug-Resistant Outbreak in NICU
- AI Helps Predict Which Heart-Failure Patients Will Worsen Within a Year
Channels
Artificial Intelligence
view channelAI Analysis of Pericardial Fat Refines Long-Term Heart Disease Risk
Accurately identifying long-term cardiovascular disease risk in asymptomatic adults remains challenging for clinicians. Missed or underestimated risk delays preventive therapy and increases the chance... Read more
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read moreSurgical Techniques
view channel
Ultrasound Technology Aims to Replace Invasive BPH Procedures
Benign prostatic hyperplasia (BPH) is a frequent cause of lower urinary tract symptoms in aging men and often requires invasive procedures or prolonged recovery. With prevalence expected to rise as populations... Read more
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel







